Characterizing the multiple roles of FGF-2 in SOD1G93A ALS mice in vivo and in vitro

被引:6
|
作者
Kefalakes, Ekaterini [1 ,2 ]
Boeselt, Sebastian [1 ]
Sarikidi, Anastasia [1 ]
Ettcheto, Miren [3 ,4 ,5 ,6 ]
Bursch, Franziska [1 ,2 ]
Naujock, Maximilian [1 ,2 ]
Stanslowsky, Nancy [1 ,2 ]
Schmuck, Martin [7 ]
Barenys, Marta [8 ,9 ]
Wegner, Florian [1 ,2 ]
Grothe, Claudia [2 ,10 ]
Petri, Susanne [1 ,2 ]
机构
[1] Hannover Med Sch, Dept Neurol, Carl Neuberg Str 1, D-30625 Hannover, Germany
[2] Ctr Syst Neurosci ZSN, Hannover, Germany
[3] Univ Barcelona, Fac Pharm & Food Sci, Dept Pharmacol Toxicol & Therapeut Chem, Barcelona, Spain
[4] Biomed Res Networking Ctr Neurodegenerat Dis CIBE, Madrid, Spain
[5] Univ Barcelona, Inst Neurosci, Barcelona, Spain
[6] Univ Rovira & Virgili, Fac Med & Life Sci, Dept Biochem, Reus, Spain
[7] Univ Calif Davis, Davis Sch Vet Med, Davis, CA 95616 USA
[8] Univ Barcelona, INSA UB, GRET, Barcelona, Spain
[9] Univ Barcelona, Fac Pharm, Pharmacol Toxicol & Therapeut Chem Dept, Toxicol Unit, Barcelona, Spain
[10] Hannover Med Sch, Inst Neuroanat & Cell Biol, Hannover, Germany
关键词
AKT; amyotrophic lateral sclerosis (ALS); astrocytes; extracellular-signal-regulated kinase (ERK); fibroblast growth factor-2 (FGF-2); glial-cell-line-derived neurotrophic factor (GDNF); motor neurons; superoxide dismutase 1 (SOD1); FIBROBLAST-GROWTH-FACTOR; FACTOR BFGF INJECTION; SPINAL-CORD; MOUSE MODEL; CELL-PROLIFERATION; SKELETAL-MUSCLE; MOTOR-NEURONS; FACTOR-2; SURVIVAL; EXPRESSION;
D O I
10.1002/jcp.27498
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have previously shown that knockout of fibroblast growth factor-2 (FGF-2) and potential compensatory effects of other growth factors result in amelioration of disease symptoms in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). ALS is a rapidly progressive neurological disorder leading to degeneration of cortical, brain stem, and spinal motor neurons followed by subsequent denervation and muscle wasting. Mutations in the superoxide dismutase 1 (SOD1) gene are responsible for approximately 20% of familial ALS cases and SOD1 mutant mice still are among the models best mimicking clinical and neuropathological characteristics of ALS. The aim of the present study was a thorough characterization of FGF-2 and other growth factors and signaling effectors in vivo in the SOD1(G93A) mouse model. We observed tissue-specific opposing gene regulation of FGF-2 and overall dysregulation of other growth factors, which in the gastrocnemius muscle was associated with reduced downstream extracellular-signal-regulated kinases (ERK) and protein kinase B (AKT) activation. To further investigate whether the effects of FGF-2 on motor neuron death are mediated by glial cells, astrocytes lacking FGF-2 were cocultured together with mutant SOD1(G93A) motor neurons. FGF-2 had an impact on motor neuron maturation indicating that astrocytic FGF-2 affects motor neurons at a developmental stage. Moreover, neuronal gene expression patterns showed FGF-2- and SOD1(G93A)-dependent changes in ciliary neurotrophic factor, glial-cell-line-derived neurotrophic factor, and ERK2, implying a potential involvement in ALS pathogenesis before the onset of clinical symptoms.
引用
收藏
页码:7395 / 7410
页数:16
相关论文
共 50 条
  • [41] Altered Expression of DJ-1 and PINK1 in Sporadic ALS and in the SOD1G93A ALS Mouse Model
    Knippenberg, Sarah
    Sipos, Julia
    Thau-Habermann, Nadine
    Koerner, Sonja
    Rath, Klaus Jan
    Dengler, Reinhard
    Petri, Susanne
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (11): : 1052 - 1061
  • [42] Isoform-selective as opposed to complete depletion of fibroblast growth factor 2 (FGF-2) has no major impact on survival and gene expression in SOD1G93A amyotrophic lateral sclerosis mice
    Kefalakes, Ekaterini
    Sarikidi, Anastasia
    Bursch, Franziska
    Ettcheto, Miren
    Schmuck, Martin
    Rumpel, Regina
    Grothe, Claudia
    Petri, Susanne
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 50 (06) : 3028 - 3045
  • [43] In vivo EPR pharmacokinetic evaluation of the redox status and the blood brain barrier permeability in the SOD1G93A ALS rat model
    Stamenkovic, Stefan
    Pavicevic, Aleksandra
    Mojovic, Milos
    Popovic-Bijelic, Ana
    Selakovic, Vesna
    Andjus, Pavle
    Bacic, Goran
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 108 : 258 - 269
  • [44] Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS
    Gabriela Bortolança Chiarotto
    Luciana Politti Cartarozzi
    Matheus Perez
    Natalia Perussi Biscola
    Aline Barroso Spejo
    Fernanda Gubert
    Marcondes França Junior
    Rosália Mendez-Otero
    Alexandre Leite Rodrigues de Oliveira
    Journal of Neuroinflammation, 16
  • [45] Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice
    Niccolai, Elena
    Di Gloria, Leandro
    Trolese, Maria Chiara
    Fabbrizio, Paola
    Baldi, Simone
    Nannini, Giulia
    Margotta, Cassandra
    Nastasi, Claudia
    Ramazzotti, Matteo
    Bartolucci, Gianluca
    Bendotti, Caterina
    Nardo, Giovanni
    Amdei, Amedeo
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01):
  • [46] Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A
    Numata-Uematsu, Yurika
    Wakatsuki, Shuji
    Nagano, Seiichi
    Shibata, Megumi
    Sakai, Kazuhisa
    Ichinohe, Noritaka
    Mikoshiba, Katsuhiko
    Ohshima, Toshio
    Yamashita, Naoya
    Goshima, Yoshiro
    Araki, Toshiyuki
    NEUROSCIENCE RESEARCH, 2019, 139 : 63 - 68
  • [47] Analysis of Feeding Behavior Characteristics in the Cu/Zn Superoxide Dismutase 1 (SOD1) SOD1G93A Mice Model for Amyotrophic Lateral Sclerosis (ALS)
    Kitaoka, Yoshihiro
    Seki, Soju
    Kawata, Sou
    Nishiura, Akira
    Kawamura, Kohei
    Hiraoka, Shin-ichiro
    Kogo, Mikihiko
    Tanaka, Susumu
    NUTRIENTS, 2023, 15 (07)
  • [48] Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1G93A Transgenic ALS Mice
    Sagit Golko-Perez
    Tamar Amit
    Moussa B. H. Youdim
    Orly Weinreb
    Journal of Molecular Neuroscience, 2016, 59 : 504 - 510
  • [49] Gene therapy for overexpressing Neuregulin 1 type I in skeletal muscles promotes functional improvement in the SOD1G93A ALS mice
    Modol-Caballero, Guillem
    Herrando-Grabulosa, Mireia
    Garcia-Lareu, Bela
    Solanes, Neus
    Verdes, Sergi
    Osta, Rosario
    Francos-Quijorna, Isaac
    Lopez-Vales, Ruben
    Cristina Calvo, Ana
    Bosch, Assumpcio
    Navarro, Xavier
    NEUROBIOLOGY OF DISEASE, 2020, 137
  • [50] Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1G93A Transgenic ALS Mice
    Golko-Perez, Sagit
    Amit, Tamar
    Youdim, Moussa B. H.
    Weinreb, Orly
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 59 (04) : 504 - 510